The company will not receive any proceeds from the sale of the shares by the selling stockholders. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on VOR: Vor Biopharma Strengthens Board with New Appointment Vor Bio appoints Kalir to board of directors Vor Bio price target lowered to $6 from $12 at JMP Securities Vor Biopharma Secures $55.6M for Cancer Therapy Trials Vor Bio prices 55.87M shares at 99.425c in private placement Disclaimer & DisclosureReport an Issue